I 

116TH CONGRESS 

2D SESSION H. R. 8652 

To amend title XVIII of the Social Security Act to provide coverage and 

payment under such title for certain treatments for dialysis-related amyloidosis, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

OCTOBER 23, 2020 

Mr. BABIN introduced the following bill; which was referred to the Committee 

on Energy and Commerce, and in addition to the Committee on Ways 

and Means, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend title XVIII of the Social Security Act to provide 

coverage and payment under such title for certain treatments for dialysis-related amyloidosis, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Dialysis-Related Amy5 loidosis Treatment Act of 2020’’. 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 8652 IH

1 SEC. 2. COVERAGE AND PAYMENT FOR TREATMENTS FOR 

2 DIALYSIS-RELATED AMYLOIDOSIS UNDER 

3 THE MEDICARE PROGRAM. 

4 (a) COVERAGE.—Section 1861(s)(2) of the Social Se5 curity Act (42 U.S.C. 1395x(s)(2)), is amended— 

6 (1) in subparagraph (GG), by striking ‘‘and’’ at 

7 the end; 

8 (2) in subparagraph (HH), by striking the pe9 riod at the end and inserting ‘‘; and’’; and 

10 (3) by adding at the end the following new sub11 paragraph: 

12 ‘‘(II) treatments for dialysis-related amyloidosis 

13 (as defined in subsection (kkk)).’’. 

14 (b) TREATMENTS FOR DIALYSIS-RELATED AMYLOI15 DOSIS DEFINED.— 

16 (1) IN GENERAL.—Section 1861 of the Social 

17 Security Act (42 U.S.C. 1395x), is amended by add18 ing at the end the following new subsection: 

19 ‘‘(kkk) TREATMENTS FOR DIALYSIS-RELATED AMY20 LOIDOSIS.—The term ‘treatments for dialysis-related amy21 loidosis’ means any item or service that is furnished in 

22 a dialysis facility (freestanding or hospital-based) that is 

23 approved by the Food and Drug Administration for the 

24 treatment of dialysis-related amyloidosis, and any supplies 

25 or services that are provided adjunct to and are necessary 

26 for such treatment.’’. 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 8652 IH

1 (2) EXCLUSION FROM RENAL DIALYSIS SERV2 ICES.—Section 1881(b)(14)(B) of the Social Secu3 rity Act (42 U.S.C. 1395rr(b)(14)(B)) is amended 

4 by inserting before the period at the end the fol5 lowing: ‘‘or ‘treatments for dialysis-related amyloi6 dosis’ (as defined in section 1861(kkk))’’. 

7 (c) PAYMENT.—Section 1833(a)(1)(E) of the Social 

8 Security Act (42 U.S.C. 1395l(a)(1)(E)) is amended by 

9 inserting at the end the following: ‘‘except for treatments 

10 for dialysis-related amyloidosis, which may not be included 

11 as a renal dialysis service for purposes of payment under 

12 any prospective payment amount or comprehensive fee es13 tablished under section 1881, and for which payment shall 

14 be made separately in the amount of 100 percent of the 

15 reasonable charges for such items and services,’’. 

16 (d) EFFECTIVE DATE.—The amendments made by 

17 this section shall take effect on the date of the enactment 

18 of this Act. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS